MemVerge is a company that is delivering the world’s first Memory-Converged Infrastructure system, built with proprietary software technology. Pulse...
Read more
Foldax announced completion of enrollment in the Indian clinical trial of the TRIA™ polymer surgical mitral heart valve.
Read more
Vivodyne announced the close of $38 million in total seed financing, led by Khosla Ventures, with participation from Kairos...
Read more
Delpor announced topline results of its DLP-114 Phase 1b/2a clinical study during which schizophrenia patients received treatment for up...
Read more
MemVerge and Sentieon announced a collaboration to accelerate next-generation sequencing (NGS) in the public cloud. MemVerge and Sentieon integrated...
Read more
Behavioral Signals has announced its work in the federal marketplace. “AI is ushering in a profound transformation in the...
Read more
PteroDynamics announced a successful demonstration of the advanced capabilities of its automated Transwing vertical takeoff and landing UAS at the...
Read more
The Retinal Degeneration Fund – the venture arm of the Foundation Fighting Blindness aimed at rapidly driving research to...
Read more
The Gut Microbiome May Unlock New Treatment Paradigms For Neurological Diseases – Axial Therapeutics
Autistic children have long been known to have differences in their gut microbiota and as a result are more...
Read more
Axial Therapeutics announced completion of enrollment in the TAPESTRY Autism Study, the Phase 2b clinical trial of its lead...
Read more